VirnetX director sells 7,500 shares under plan

VirnetX director Gary Feiner disclosed 7,500 shares of open-market sales executed under a pre-arranged Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

VirnetX Holding Corp (VHC) director Gary Feiner reported open-market sales of an aggregate 7,500 shares of common stock in late August and early September 2026. The trades were effected under a Rule 10b5-1 trading plan adopted on May 29, 2026, with prices reported on a weighted-average basis within disclosed ranges.

Insider Trade Summary 10b5-1

Net Seller: 7,500 shares

Net Sell 3 txns

Insider Feiner Gary

Role Director

Sold 7,500 shs ($83K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F3	3,750	$11.001	$41K
Sale	Common Stock F1, F2	3,749	$11.172	$42K
Sale	Common Stock F1	1	$12.03	$12.03

Holdings After Transaction: Common Stock — 16,874 shares (Direct)

Footnotes (3)

1. F1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026.
2. F2. This sale price represents the weighted average sale price of the shares sold ranging from $11.00 to $11.615 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
3. F3. This sale price represents the weighted average sale price of the shares sold ranging from $10.63 to $11.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Key Figures

Shares sold September 1, 2026: 3,750 shares of common stock Shares sold August 31, 2026 (block): 3,749 shares of common stock Additional shares sold August 31, 2026: 1 share of common stock +1 more

4 metrics

Shares sold September 1, 2026 3,750 shares of common stock Open-market sale at a reported weighted average of $11.001 per share

Shares sold August 31, 2026 (block) 3,749 shares of common stock Open-market sale at a reported weighted average of $11.172 per share

Additional shares sold August 31, 2026 1 share of common stock Open-market sale at $12.03 per share

Total shares sold 7,500 shares of common stock Aggregate of three reported sales on August 31 and September 1, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"This sale price represents the weighted average sale price of the shares sold"

open market or private transaction market

"Sale in open market or private transaction"

FAQ

What insider transaction did VirnetX (VHC) director Gary Feiner report?

Gary Feiner reported sales of 7,500 VirnetX common shares in open-market transactions on August 31 and September 1, 2026. The filing lists three non-derivative sales coded as dispositions of common stock.

On what dates did the VirnetX (VHC) insider trades occur?

The reported trades occurred on August 31, 2026 and September 1, 2026. Two transactions, including 3,749 shares and 1 share, were dated August 31, and one transaction of 3,750 shares was dated September 1.

At what prices were the VirnetX (VHC) shares sold by the director?

Reported prices were $11.172 and $12.03 per share on August 31, 2026, and $11.001 per share on September 1, 2026. Footnotes state these figures are weighted average sale prices across price ranges for the larger blocks.

Was the VirnetX (VHC) insider selling under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026, indicating they followed a pre-arranged trading schedule rather than ad hoc timing.

How many VirnetX (VHC) shares did the director sell in total?

Across the three reported transactions, Gary Feiner sold an aggregate of 7,500 shares of VirnetX common stock. This total comes from blocks of 3,750 shares, 3,749 shares, and 1 share, all classified as open-market or private sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:05 PM Accepted by SEC EDGAR 09/02/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feiner Gary

(Last) (First) (Middle)

C/O 308 DORLA COURT, SUITE 206

(Street)

ZEPHYR COVE NEVADA 89448

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VirnetX Holding Corp [ VHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2026		S(1)		3,749	D	$11.172(2)	20,625	D
Common Stock	08/31/2026		S(1)		1	D	$12.03	20,624	D
Common Stock	09/01/2026		S(1)		3,750	D	$11.001(3)	16,874	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026.

2. This sale price represents the weighted average sale price of the shares sold ranging from $11.00 to $11.615 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

3. This sale price represents the weighted average sale price of the shares sold ranging from $10.63 to $11.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Kendall Larsen, Attorney-in-fact for Gary Feiner	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)